The different pleuro-pulmonary pathologies related to asbestos: Definitions, epidemiology and evolution;Les différentes pathologies pleuropulmonaires liées à l'amiante : Définitions, épidémiologie et évolution

Revue des Maladies Respiratoires

Volumn 29, Issue 8, 2012, Pages 1035-1046

  Ameille, J ^a,b  

^a RAYMOND POINCARÉ HOSPITAL   (France)

^b LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

Asbestos; Bronchial carcinoma; Epidemiology; Mesothelioma; Pleural plaques

Indexed keywords

ASBESTOS;

ARTICLE; ASBESTOSIS; CANCER INCIDENCE; CANCER RISK; DISEASE ASSOCIATION; DISEASE COURSE; FRANCE; HUMAN; LUNG CANCER; LUNG FIBROSIS; MESOTHELIOMA; PLEURA PLAQUE;

EID: 84873057645     PISSN: 07618425     EISSN: 17762588     Source Type: Journal    
DOI: 10.1016/j.rmr.2012.02.012     Document Type: Review

References (128)

1. American Thoracic Society Documents. Diagnosis and initial management of nonmalignant diseases related to asbestos. Am J Respir Crit Care Med 2004;170:691 - 715.
2. Ameille J, Brochard P, Pairon JC. Amiante et pathologie professionnelle. Masson ed; 2000, 188
3. Letourneux M, Paris C, Pommier De Santi P, Clin B, et al. Affections pleuropulmonaires bénignes liées à l'amiante. Rev Mal Respir 2007;24:1299 - 313.
4. Copley SJ, Wells AU, Sivakumaran P, et al. Asbestosis and idiopathic pulmonary fibrosis: Comparison of thin-section CT features. Radiology 2003;229:731 - 6.
5. Green RA, Dimcheff DG. Massive bilateral upper lobe fibrosis secondary to asbestos exposure. Chest 1974;65:52 - 5.
6. Hillerdal G. Pleural and parenchymal fibrosis mainly affecting the upper lung lobes in persons exposed to asbestos. Respir Med 1990;84:129 - 34.
7. International Labour Office. Guidelines for the use of the ILO classification of radiographs of pneumoconiosis, revised edition 2000. International Labour Office Occupational Safety and Health series no 22. Geneva: ILO; 2002.
8. Meyer JD, Islam SS, Ducatman AM, et al. Prevalence of small lung opacities in populations unexposed to dusts. A literature analysis. Chest 1997;111:404 - 10.
9. Rockoff SD, Schwartz A. Roentgenographic underestimation of early asbestosis by International Labor Organization classification. Analysis of data and probabilities. Chest 1988;93:1088 - 91.
10. Gefter WB, Conant EF. Issues and controversies in the plainfilm diagnosis of asbestos-related disorders in the chest. J Thorac Imaging 1988;3:11 - 28.
11. Gevenois PA, De Vuyst P, Dedeire S, Cosaert J, et al. Conventional and high-resolution CT in asymptomatic asbestos-exposed workers. Acta Radiologica 1994;35:226 - 9.
12. Aberle DR, Gamsu G, Ray CS. High-resolution CT of benign asbestos-related diseases: Clinical and radiographic correlation. AJR 1988;151:883 - 91.
13. Neri S, Antonelli A, Falashi F, Boraschi P, et al. Findings from high-resolution computed tomography of the lung and pleura of symptom free workers exposed to amosite who had normal chest radiographs and pulmonary function tests. Occup Environ Med 1994;51:239 - 43.
14. Staples CA, Gamsu G, Ray CS, et al. High resolution computed tomography and lung function in asbestos-exposed workers with normal chest radiographs. Am Rev Respir Dis 1989;139:1502 - 8.
15. Friedman AC, Fiel SB, Fisher MS, et al. Asbestos-related pleural disease and asbestosis: A comparison of CT and chest radiography. AJR Am J Roentgenol 1988;150:269 - 75.
16. Aberle DR, Gamsu G, Ray CS, et al. Asbestos-related pleural and parenchymal fibrosis: Detection with high-resolution CT. Radiology 1988;166:729 - 34.
17. Copley S. Asbestosis. In: Gevenois PADVP, editor. Imaging of Occupational and Environmental Disorders of the Chest. Berlin Heidelberg: Springer; 2006. p. 207 - 21.
18. Al-Jarad N, Strickland B, Pearson MC, Rubens MB, Rudd RM. High resolution computed tomographic assessment of asbestosis and cryptogenic fibrosing alveolitis: A comparative study. Thorax 1992;47:645 - 50.
19. Akira M, Yamamoto S, Yokoyama K, Kita N, et al. Asbestosis: High-resolution CT-pathologic correlation. Radiology 1990;176:389 - 94.
20. Webb WRMN, Naidich DP. Chapter 4, Diseases characterized primarily by linear and reticular opacities. In: High-resolution CT of the Lung. 3rd ed Philadelphia: Lippincott Williams & Wilkins; 2001, p 236 - 51.
21. Gevenois P, de Maertelaer V, Madani A, et al. Asbestosis, pleural plaques and diffuse pleural thickening: Three distinct benign responses to asbestos exposure. Eur Respir J 1998;11:1021 - 7.
22. Samet J, Epler G, Gaensler E, et al. Absence of synergism between exposure to asbestos and cigarette smoking in asbestosis. Am Rev Respir Dis 1979;121:75 - 82.
23. Hnizdo E, Sluis-Cremer GK. Effect of tobacco smoking on the presence of asbestosis at postmortem and on the reading of irregular opacities on roentgenograms in asbestos-exposed workers. Am Rev Respir Dis 1988;138:1207 - 12.
24. Barnhart S, Thornquist MD, Omenn GS, et al. The degree of roentgenographic parenchymal opacities attributable to smoking among asbestos-exposed subjects. Am Rev Respir Dis 1990;141:1102 - 6.
25. Lilis R, Selikoff I, Lerman Y, et al. Asbestosis. Interstitial pulmonary fibrosis and pleural fibrosis in a cohort of asbestos insulation workers: Influence of cigarette smoking. Am J Ind Med 1986;10:459 - 70.
26. Ameille J, Matrat M, Paris C, et al. Asbestos-related pleural diseases: Dimensional criteria are not appropriate to differentiate diffuse pleural thickening from pleural plaques. Am J Ind Med 2004;45:289 - 96.
27. Greenberg SD. Benign asbestos-related pleural diseases. In: Roggli VL, Greenberg SD, Pratt DC, editors. Pathology of asbestos-associated diseases. Boston, Toronto, London: Little, Brown and company; 1992. p. 165 - 87.
28. Rudd RM. New developments in asbestos-related pleural disease. Thorax 1996;51:210 - 6.
29. Peacock C, Espley SJ, Hansell DM. Asbestos-related benign pleural disease. Clin Radiol 2000;55:422 - 32.
30. Ugell DW, Kamp DW. Asbestos and the pleura. A review. Chest 2004;125:1103 - 17.
31. Järvholm B, Arvidsson H, Bake B, et al. Pleural plaquesasbestos- ill-health. Eur J Respir Dis 1986;68:1 - 59.
32. Hillerdal G. Non malignant asbestos pleural disease. Thorax 1981;39:669 - 75.
33. Müller NL. Imaging of the pleura. Radiology 1993;186:297 - 309.
34. Beigelman-Aubry C, Ferretti G, Mompoint D, et al. Atlas iconographique tomodensitométrique des pathologies bénignes de l'amiante. Rev Mal Respir 2007;24:759 - 81.
35. Lockey JE, LeMasters GK, Levin L, et al. A longitudinal study of chest radiographic changes of workers in the refractory ceramic fiber industry. Chest 2002;121:2044 - 51.
36. Emri S, Demir A, Dogan M, et al. Lung diseases due to environmental exposures to erionite and asbestos in Turkey. Toxicol Lett 2002;28:251 - 7.
37. Weiss W, Levin R, Goodman L. Pleural plaques and cigarette smoking in asbestos workers. J Occup Med 1981;23:427 - 30.
38. Rosenstock L, Barhart S, Heyer NJ, et al. The relation among pulmonary function, chest roentgenographic abnormalities, and smoking status in an asbestos-exposed cohort. Am Rev Respir Dis 1988;136:272 - 7.
39. Delclos GL, Wilson K, Bradley BL. Influence of smoking on radiographic profusion and pleural changes in asbestosexposed subjects. J Occup Med 1990;32:577 - 81.
40. Eisenstadt HB. Asbestos pleurisy. Dis Chest 1964;46:78 - 81.
41. Martensson G, Hagberg S, Patterson K, et al. Asbestos pleural effusion: A clinical entity. Thorax 1987;42:646 - 51.
42. Hillerdal G, Ozesmi M. Benign asbestos pleural effusion: 73 exudates in 60 patients. Eur J Respir Dis 1987;71:113 - 21.
43. Epler GR, McLoud TC, Gaensler EA. Prevalence and incidence of benign asbestos pleural effusion in a working population. JAMA 1982;247:617 - 22.
44. Lilis R, Lerman Y, Selikoff IJ. Symptomatic benign pleural effusion among asbestos insulation workers: Residual radiographic abnormalities. Brit J Ind Med 1988;45:443 - 9.
45. McLoud TC, Woods BO, Carrington CB, et al. Diffuse pleural thickening in an asbestos-exposed population: Prevalence and causes. AJR 1985;144:9 - 18.
46. Sargent EN, Gardanson JS, Jacobson G, et al. Bilateral pleural thickening: A manifestation of asbestos dust exposure. AJR 1978;131:579 - 85.
47. Lynch DA, Gamsu G, Aberle DR. Conventional and high resolution computed tomography in the diagnosis of asbestosrelated diseases. Radiographics 1989;9:S23 - 51.
48. Webb WR, Miller NL, Naidich DP. Diseases characterized primarily by linear and reticular opacities. In: Webb WR, Müler NL, Naidich DP, editors. High-resolution CT of the lung. Philadelphia, New York: Lippincott-Raven publishers; 1996. p. 109 - 48.
49. Yates DH, Browne K, Stidolph PH, et al. Asbestos-related bilateral diffuse pleural thickening: Natural history of radiographic and lung function abnormalities. Am J Respir Crit Care Med 1996;153:303 - 6.
50. Astoul P, Ménard O. Quels critères diagnostiques pour le mésothéliome pleural malin ? Rev Mal Respir 2006;23, 11S29 - 35.
51. Galateau-Sallé F, Copin MC, Delajartre AY, et al. Quels critères pour le diagnostic anatomopathologique du mésothé liome pleural malin ? Rev Mal Respir 2006;23, 11S37 - 44.
52. Metintas S, Metintas M, Ucgun I, et al. Malignant mesothelioma due to environmental exposure to asbestos: Follow-up of a Turkish cohort living in a rural area. Chest 2002;122:2224 - 9.
53. Comba P, Gianfagna A, Paoletti L. Pleural mesothelioma cases in Biancavilla are related to a new fluoro-edenite fibrous amphibole. Arch Environ Health 2003;58:229 - 32.
54. IARC. Man-made vitreous fibres. IARC Monogr Eval Carcinog Risks Hum 2002;81, 418
55. Cavazza A, Travis LB, Travis WD, et al. Post-irradiation malignant mesothelioma. Cancer 1996;77:1379 - 85.
56. Travis LB, Fossa SD, Schonfeld SJ, et al. Second cancers among 40,576 testicular cancer patients: Focus on long-term survivors. J Natl Cancer Inst 2005;97:1354 - 65.
57. Tward JD, Wendland MM, Shrieve DC, et al. The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma. Cancer 2006;107:108 - 15.
58. Andersson M, Wallin H, Jönsson M, et al. Lung carcinoma and malignant mesothelioma in patients exposed to Thorotrast: Incidence, histology and p53 status. Int J Cancer 1995;63:330 - 6.
59. Van Kaick G, Dalheimer A, Hornik S, et al. The german thorotrast study: Recent results and assessment of risks. Radiat Res 1999;152:S64 - 71.
60. Carbone M, Pass HI, Rizzo P, et al. Simian virus 40-like DNA sequences in human pleural mesothelioma. Oncogene 1994;9:1781 - 90.
61. Carbone M, Pass HI, Miele L, et al. New developments about the association of SV40 with human mesothelioma. Oncogene 2003;22:5173 - 80.
62. Gazdar AF, Carbone M. Molecular pathogenesis of malignant mesothelioma and its relationship to simian virus 40. Clin Lung Cancer 2003;5:177 - 81.
63. Pairon JC, Andujar P, Matrat M, et al. Cancers respiratoires professionnels. Rev Mal Respir 2008;25:193 - 207.
64. Inserm. Effets sur la santé des principaux types d'exposition à l'amiante. Rapport d'expertise collective. Paris: Editions Inserm; 1997, 434
65. Lee PN. Relation between exposure to asbestos and smoking jointly and the risk of lung cancer. Occup Environ Med 2001;58:145 - 53.
66. Gustavsson P, Nyberg F, Pershagen G, et al. Low-dose exposure to asbestos and lung cancer: Dose-response relations and interaction with smoking in an population-based case-referent study in Stockholm, Sweden. Am J Epidemiol 2002;155:1016 - 22.
67. Wraith D, Mengersen K. Assessing the combined effect of asbestos exposure and smoking on lung cancer: A Bayesian approach. Stat Med 2007;26:1150 - 69.
68. Caisse Nationale d'Assurance Maladie des Travailleurs Salariés. Direction des risques professionnels. Dénombrement des maladies professionnelles déclarées et reconnues par le régime général de 2004 à 2007. Rapport mars 2009. www.risquesprofessionnels.ameli.fr
69. Koskinen K, Zitting A, Tossavainen A, et al. Radiographic abnormalities among Finnish construction, shipyard and asbestos industry workers. Scand J Work Environ Health 1998;24:109 - 17.
70. Henneberger PK, Stanbury MJ. Patterns of asbestosis in New Jersey. Am J Ind Med 1992;21:689 - 97.
71. Ohar J, Sterling DA, Bleecker E, et al. Changing patterns in asbestos-induced lung disease. Chest 2004;125:744 - 53.
72. Algranti E, Mendonca EM, DeCapitani EM, et al. Non-malignant asbestos-related diseases in Brazilian asbestos-cement workers. Am J Ind Med 2001;40:240 - 54.
73. Van Cleemput J, De RH, Verschakelen JA, et al. Surface of localized pleural plaques quantitated by computed tomography scanning: No relation with cumulative asbestos exposure and no effect on lung function. Am J Respir Crit Care Med 2001;163:705 - 10.
74. De Raeve H, Verschakelen JA, Gevenois PA, et al. Observer variation in computed tomography of pleural lesions in subjects exposed to indoor asbestos. Eur Respir J 2001;17:916 - 21.
75. Paris C, Benichou J, Raffaelli C, et al. Factors associated with early-stage pulmonary fibrosis as determined by high-resolution computed tomography among persons occupationally exposed to asbestos. Scand J Work Environ Health 2004;30:206 - 14.
76. Ameille J, Mattei N, Laurent F, et al. Computed tomographyfindings in urban transportation workers with low cumulative asbestos exposure. Int J Tuberc Lung Dis 2007;11:1352 - 7.
77. Paris C, Martin A, Letourneux M, et al. Modelling prevalence and incidence of fibrosis and pleural plaques in asbestos-exposed populations for screening and follow-up: A cross-sectional study. Environ Health 2008;7:30.
78. Paris C, Thierry S, Brochard P, et al. Pleural plaques and asbestosis: Dose and time response relationships based on HRCT data. Eur Respir J 2009;34:72 - 9.
79. Mastrangelo G, Ballarin MN, Bellini E, et al. Asbestos exposure and benign asbestos diseases in 772 formerly exposed workers: Dose-response relationships. Am J Ind Med 2009;52:596 - 602.
80. Anonymous. Changing patterns of pneumoconiosis mortality - United States, 1968 - 2000. MMWR 2004;53:627 - 32.
81. Dos Santos Antao VC, Pinheiro GA, Wassel JT. Asbestosis mortality in the USA: Facts and prediction. Occup Environ Med 2009;66:335 - 8.
82. Schwartz DA. New developments in asbestos-induced pleural disease. Chest 1991;99:191 - 8.
83. Letourneux M. Évaluation du risque de survenue des pathologies asbestosiques bénignes (relation dose-effet, relation temps-effet, co-facteurs). Rev Mal Respir 1999;16: 1270 - 7.
84. de Klerk NH, Cookson WO, Musk AW, et al. Natural history of pleural thickening after exposure to crocidolite. Br J Ind Med 1989;46:461 - 7.
85. Ehrlich R, Lilis R, Chan E, et al. Long term radiological effects of short term exposure to amosite asbestos among factory workers. Br J Ind Med 1992;49:268 - 75.
86. Järvholm B. Pleural plaques and exposure to asbestos: A mathematical model. Int J Epidemiol 1992;21:1180 - 4.
87. Yates DH, Corrin B, Stidolph PN, et al. Malignant mesothelioma in South East England: Clinicopathological experience of 272 cases. Thorax 1997;52:507 - 12.
88. Lanphear BP, Buncher CR. Latent period for malignant mesothelioma of occupational origin. J Occup Med 1992;34:718 - 21.
89. Robinson BWS, Lake RA. Advances in malignant mesothelioma. N Eng J Med 2005;353:1591 - 603.
90. Goldberg M, Imbernon E, Rolland P, et al. The French National Mesothelioma Surveillance Program. Occup Environ Med 2006;63:390 - 5.
91. Rake C, Gilham C, Hatch J, et al. Occupational, domestic and environmental mesothelioma risks in the British population: A case-control study. Br J Cancer 2009;100:1175 - 83.
92. Scherpereel A, Astoul P, Baas P, et al. Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for management of Malignant Pleural Mesothelioma. Eur Respir J 2009 [Epub ahead of print].
93. Peto J, Hodgson JT, Matthews FE, et al. Continuing increase in mesothelioma mortality in Britain. Lancet 1995;345: 535 - 9.
94. Peto J, Decarli A, La Vecchia C, et al. The European mesothelioma epidemic. Br J Cancer 1999;79:666 - 72.
95. Gilg Soit Ilg A, Bignon J, Valleron AJ. Estimation of the past and future burden of mortality from mesothelioma in France. Occup Environ Med 1998;55:760 - 5.
96. Banaei A, Auvert B, Goldberg M, et al. Future trends in mortality of French men from mesothelioma. Occup Environ Med 2000;57:488 - 94.
97. Weill H, Hughes JM, Churg AM. Changing trends in US mesothelioma incidence. Occup Environ Med 2004;61:438 - 41.
98. Hodgson JT, McElvenny DM, Darnton AJ, et al. The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050. Br J Cancer 2005;92:587 - 93.
99. Segura O, Burdorf A, Looman C. Update of predictions of mortality from pleural mesothelioma in the Netherlands. Occup Environ Med 2003;60:50 - 5.
100. Montanaro F, Bray F, Gennaro V, et al. Pleural mesothelioma incidence in Europe: Evidence of some deceleration in the increasing trends. Cancer Causes Control 2003;14:791 - 803.
101. Pelucchi C, Malvezzi M, La Vecchia C, et al. The mesothelioma epidemic in Western Europe: An update. Br J Cancer 2004;90:1022 - 4.
102. Hemminki K, Li X. Mesothelioma incidence seems to have leveled off in Sweden. Int J Cancer 2003;103:145 - 6.
103. Price B, Ware A. Mesothelioma trends in the United States: An update based on Surveillance, Epidemiology, and End Results Program data for 1973 through 2003. Am J Epidemiol 2004;159:107 - 12.
104. Le Stang N, Belot A, Gilg Soit Ilg A, et al. Evolution of pleural cancers and malignant pleural mesothelioma incidence in France between 1980 and 2005. Int J Cancer 2010;126:232 - 8.
105. Albin M, Magnani C, Krstev S, et al. Asbestos and cancer: An overview of current trends in Europe. Environ Health Perspect 1999;107:289 - 98.
106. Imbernon E. Estimation du nombre de cas de certains cancers attribuables à des facteurs professionnels. Institut de veille sanitaire, avril 2003.
107. Académie nationale de médecine, Académie des sciences, Institut de France, Centre international de recherche sur le cancer (OMS Lyon), Fédération nationale des centres de lute contre le cancer, avec le concours de l'Institut national du cancer et de l'Institut national de veille sanitaire. Les causes du cancer en France. Rapport septembre 2007.
108. Sluis-Cremer GK, Hnizdo E. Progression of irregular opacities in asbestos miners. Br J Ind Med 1989;46:846 - 52.
109. Silva CI, Muller NL, Neder JA, et al. Asbestos-related disease: Progression of parenchymal abnormalities on high-resolution CT. J Thorac Imaging 2008;23:251 - 7.
110. Cookson W, De Klerk N, Musk AW, et al. The natural history of asbestosis in former crocidolite workers of Wittenoom Gorge. Am Rev Respir Dis 1986;133:994 - 8.
111. Becklake MR, Liddell FD, Manfreda J, et al. Radiological changes after withdrawal from asbestos exposure. Br J Ind Med 1979;36:23 - 8.
112. Jakobsson K, Stromberg U, Albin M, et al. Radiological changes in asbestos cement workers. Occup Environ Med 1995;52:20 - 7.
113. Viallat JR, Boutin C, Pietri JF, et al. Late progression of radiographicchanges in Canari chrysotile mine and mill exworkers. Arch Environ Health 1983;38:54 - 8.
114. Ameille J, Brochard P, Letourneux M, et al. Risque de cancer lié à l'amiante en présence d'asbestose ou de plaques pleurales. Rev Mal Respir 2009;26:413 - 21.
115. Hughes JM, Weill H. Asbestosis as a precursor of asbestos related lung cancer: Results of a prospective mortality study. Br J Ind Med 1991;48:229 - 33.
116. Hillerdal G. Pleural plaques and risk for bronchial carcinoma and mesothelioma: A prospective study. Chest 1994;105:144 - 50.
117. Wilkinson P, Hansell DM, Janssens J, et al. Is lung cancer associated with asbestos exposure when there are no small opacities on the chest radiograph? Lancet 1995;345:1074 - 8.
118. Finkelstein MM. Radiographic asbestosis is not a prerequisite for asbestos-associated lung cancer in Ontario asbestoscement workers. Am J Ind Med 1997;32:341 - 8.
119. Cullen MR, Barnett MJ, Balmes JR, et al. Predictors of lung cancer among asbestos-exposed men in the ̈-carotene and retinol efficacy trial. Am J Epidemiol 2005;161:260 - 70.
120. Imbernon E, Goldberg M, Bonenfant S, et al. Occupational respiratory cancer and exposure to asbestos: A case-control study in a cohort of workers in the electricity and gas industry. Am J Ind Med 1995;28:339 - 52.
121. Meguellati-Hakkas D, Cyr D, Stücker I, et al. Lung cancer mortality and occupational exposure to asbestos among telephone linemen: A historical cohort study in France. J Occup Environ Med 2006;48:1166 - 72.
122. Pohlabeln H, Wild P, Schill W, et al. Asbestos fibreyears and lung cancer: A two phase case-control study with expert exposure assessment. Occup Environ Med 2002;59:410 - 4.
123. Reid A, de Klerk N, Ambrosini GL, et al. The effect of asbestosis on lung cancer risk beyond the dose related effect of asbestos alone. Occup Environ Med 2005;62:885 - 9.
124. Oksa P, Klockars MM, Karjalainen A, et al. Progression of asbestosis predicts lung cancer. Chest 1998;113:1517 - 21.
125. Weiss W. Asbestos-related plaques and lung cancer. Chest 1993;103:1854 - 9.
126. Karjalainen A, Pukkala E, Kauppinen T, et al. Incidence of cancer among Finnish patients with asbestos-related pulmonary or pleural fibrosis. Cancer Causes Control 1999;10:51 - 7.
127. Reid A, de Klerk N, Ambrosini G, et al. The additional risk of malignant mesothelioma in former workers and residents of Wittenoom with benign pleural disease or asbestosis. Occup Environ Med 2005;62:665 - 9.
128. Goldberg M. Are lung and pleural benign asbestos induces diseases a preliminary step in the pathogenic process of mesothelioma and lung cancer development? Occup Environ Med 2005;62:663 - 4.